Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Parnell Pharmaceuticals (CE) (PARNF)

Parnell Pharmaceuticals Holdings Ltd (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PARNF
DateTimeSourceHeadlineSymbolCompany
07/08/201719:41Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/08/201716:15Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
31/03/201713:36Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/03/201720:18Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
14/02/201716:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/01/201717:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/01/201711:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
03/01/201711:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/12/201619:51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/12/201619:46Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/12/201619:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/12/201619:37Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
21/12/201614:43Edgar (US Regulatory)(25)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
19/12/201621:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
19/12/201621:30GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
09/12/201622:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
09/12/201622:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
01/12/201612:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
30/11/201612:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
23/11/201603:34GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan FacilityUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
02/11/201620:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
02/11/201620:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
27/10/201619:49GlobeNewswire Inc.Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201615:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201611:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
04/08/201611:00GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
26/07/201621:00GlobeNewswire Inc.Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
31/05/201620:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
31/05/201620:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
31/05/201620:05GlobeNewswire Inc.Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with MerialUSOTC:PARNFParnell Pharmaceuticals Holdings Ltd (CE)
 Showing the most relevant articles for your search:USOTC:PARNF